Search research articles
Contact Us
Filters
Showing results (291-300 of 721) with videos related to
Page
of 73
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
August 8, 2007
Prediction of tumor response by FDG-PET: comparison of the accuracy of single and sequential studies in patients with adenocarcinomas of the esophagogastric junction
Hinrich A Wieder, Katja Ott, Florian Lordick, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 9, 2017
PSMA Ligands for PET Imaging of Prostate Cancer
Sarah M Schwarzenboeck, Isabel Rauscher, Christina Bluemel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 24, 2020
PSMA-Ligand PET for Early Castration-Resistant Prostate Cancer: A Retrospective Single-Center Study
Manuel Weber, Claudia Kurek, Francesco Barbato, et al.
Theranostics
|
February 16, 2016
11C-Methionine-PET in Multiple Myeloma: Correlation with Clinical Parameters and Bone Marrow Involvement
Constantin Lapa, Stefan Knop, Martin Schreder, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 2, 2022
Unspecific <sup>18</sup>F-PSMA-1007 Bone Uptake Evaluated Through PSMA-11 PET, Bone Scanning, and MRI Triple Validation in Patients with Biochemical Recurrence of Prostate Cancer
Robert Seifert, Tugce Telli, Marcel Opitz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 5, 2016
Human Biodistribution and Radiation Dosimetry of <sup>18</sup>F-Clofarabine, a PET Probe Targeting the Deoxyribonucleoside Salvage Pathway
Martin J Barrio, Claudio Spick, Caius G Radu, et al.
Plos One
|
February 23, 2017
Whole-body staging of female patients with recurrent pelvic malignancies: Ultra-fast 18F-FDG PET/MRI compared to 18F-FDG PET/CT and CT
Julian Kirchner, Lino Morris Sawicki, Saravanabavaan Suntharalingam, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 26, 2019
<sup>18</sup>F-FDG PET-MR enterography in predicting histological active disease using the Nancy index in ulcerative colitis: a randomized controlled trial
Yan Li, Benedikt Schaarschmidt, Lale Umutlu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 21, 2024
Dose-Response Relationship in Patients with Liver Metastases from Neuroendocrine Neoplasms Undergoing Radioembolization with <sup>90</sup>Y Glass Microspheres
Masao Watanabe, Stephan Leyser, Jens Theysohn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 4, 2018
Assessment of Ileocolonic Inflammation in Crohn's Disease: Which Surrogate Marker Is Better-MaRIA, Clermont, or PET/MR Index? Initial Results of a Feasibility Trial
Yan Li, Jost Langhorst, Anna Katharina Koch, et al.
Page
of 73
Search research articles
Search
Showing results (291-300 of 721) with videos related to
Sort By:
Page
of 73
European Journal of Nuclear Medicine and Molecular Imaging
|
August 8, 2007
Prediction of tumor response by FDG-PET: comparison of the accuracy of single and sequential studies in patients with adenocarcinomas of the esophagogastric junction
Hinrich A Wieder, Katja Ott, Florian Lordick, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 9, 2017
PSMA Ligands for PET Imaging of Prostate Cancer
Sarah M Schwarzenboeck, Isabel Rauscher, Christina Bluemel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 24, 2020
PSMA-Ligand PET for Early Castration-Resistant Prostate Cancer: A Retrospective Single-Center Study
Manuel Weber, Claudia Kurek, Francesco Barbato, et al.
Theranostics
|
February 16, 2016
11C-Methionine-PET in Multiple Myeloma: Correlation with Clinical Parameters and Bone Marrow Involvement
Constantin Lapa, Stefan Knop, Martin Schreder, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 2, 2022
Unspecific <sup>18</sup>F-PSMA-1007 Bone Uptake Evaluated Through PSMA-11 PET, Bone Scanning, and MRI Triple Validation in Patients with Biochemical Recurrence of Prostate Cancer
Robert Seifert, Tugce Telli, Marcel Opitz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 5, 2016
Human Biodistribution and Radiation Dosimetry of <sup>18</sup>F-Clofarabine, a PET Probe Targeting the Deoxyribonucleoside Salvage Pathway
Martin J Barrio, Claudio Spick, Caius G Radu, et al.
Plos One
|
February 23, 2017
Whole-body staging of female patients with recurrent pelvic malignancies: Ultra-fast 18F-FDG PET/MRI compared to 18F-FDG PET/CT and CT
Julian Kirchner, Lino Morris Sawicki, Saravanabavaan Suntharalingam, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 26, 2019
<sup>18</sup>F-FDG PET-MR enterography in predicting histological active disease using the Nancy index in ulcerative colitis: a randomized controlled trial
Yan Li, Benedikt Schaarschmidt, Lale Umutlu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 21, 2024
Dose-Response Relationship in Patients with Liver Metastases from Neuroendocrine Neoplasms Undergoing Radioembolization with <sup>90</sup>Y Glass Microspheres
Masao Watanabe, Stephan Leyser, Jens Theysohn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 4, 2018
Assessment of Ileocolonic Inflammation in Crohn's Disease: Which Surrogate Marker Is Better-MaRIA, Clermont, or PET/MR Index? Initial Results of a Feasibility Trial
Yan Li, Jost Langhorst, Anna Katharina Koch, et al.
Page
of 73